Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

BIOLOGICAL2 trials

Sponsors

Sanofi Pasteur, a Sanofi Company

Conditions

Cholera

Phase 3

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in Dominican Republic

CompletedNCT02434822

Sanofi Pasteur, a Sanofi CompanyCholera

Start: 2015-04-30End: 2016-07-31Updated: 2018-03-26

Phase 4

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

CompletedNCT01949675

Sanofi Pasteur, a Sanofi CompanyCholera

Start: 2014-03-31End: 2015-08-31Updated: 2018-03-23

Related Papers

Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial

Human Vaccines & Immunotherapeutics2018-02-221 citations